The Church of Psilomethoxin Part 2: Unraveling the Sacred Chemistry
May 3, 2023
Psymposia’s investigation into the Church of Psilomethoxin (CoP) turns to the Church’s claims that it’s currently “scientifically impossible” to test for psilomethoxin. Psychedelic chemist David Nichols calls that claim “completely nonsensical and nonscientific.
Coronavirus Conspiracy Theories in Psychedelia
September 4, 2020
Conspiracy theories are nothing new when it comes to psychedelia. But in the context of coronavirus, they've become significantly more harmful.
We talked with Michael Verdon, an artist who burns down his work.
November 10, 2016
We talked with Michael Verdon, the artist behind the burning temple at Catharsis on the Mall
The Masters of Bad Trips
November 11, 2021
As proponents of psychedelics begin to grapple with legacies of abuse, it’s time to learn from victims themselves. Psymposia is co-producing an investigative podcast series, Power Trip, with New York Magazine.
Magical (Psychedelic) Thinking in the Era of Climate Change and COVID-19
July 11, 2020
Two of our biggest crises—COVID-19 and climate change—lay bare the magical thinking that pervades psychedelic discourse: that individual experiences of oneness will necessarily transform our society for the better.
A Brief History of the Drug War
May 17, 2017
Why are some drugs legal and other drugs illegal? It's not based on science or the relative risks – but has everything to do with who is associated with them.
We talked to Duncan Trussell about Microdosing and Donald Trump
December 7, 2016
"The Trump victory is like watching a dart trap set up by the Founding Fathers spring into action. For better or for worse the system worked."
Church of Psilomethoxin, Part 3: Matters of Faith. Father, Son, and Wholly Dosed?
May 9, 2023
The Church of Psilomethoxin now admits that its claims about psilomethoxin are solely based on faith. But how strong are the religious convictions of the Church?
COMPASS Pathways’ Psilocybin Patent Questioned By UK Patent Examiner
August 5, 2021
While COMPASS has issued a response defending the validity of its patents, one of the co-inventors says the patent examiner’s opinion is probably “a valid one.”
“Making psychedelics boring again”— Unless you’re a privileged psychedelic executive, of course
March 11, 2020
The new leaders of the psychedelic medicalization industry seem to see themselves as above their own self-proposed rules.